Complex therapies and multimodal interventions have become the gold standard approach for many of the most aggressive tumour types. However, there is a lack of models that enable the development and clinical translation of such treatment concepts. Can porcine cancer models fill the gap?
References
Kalla, D., Kind, A. & Schnieke, A. Genetically engineered pigs to study cancer. Int. J. Mol. Sci. 21, 488 (2020).
Pabst, R. The pig as a model for immunology research. Cell Tissue Res. 380, 287–304 (2020).
Callesen, M. M. et al. A genetically inducible porcine model of intestinal cancer. Mol. Oncol. 11, 1616–1629 (2017).
Flisikowska, T. et al. A porcine model of familial adenomatous polyposis. Gastroenterology 143, 1173–1175 (2012).
Rogalla, S. et al. Biodegradable fluorescent nanoparticles for endoscopic detection of colorectal carcinogenesis. Adv. Funct. Mater. 29, 1904992 (2019).
Hendricks-Wenger, A. et al. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Sci. Rep. 11, 7584 (2021).
Boas, F. E. et al. Induction and characterization of pancreatic cancer in a transgenic pig model. PloS ONE 15, e0239391 (2020).
Kalla, D. et al. The missing link: Cre pigs for cancer research. Front. Oncol. 11, 755746 (2021).
Wang, K. et al. Cre-dependent Cas9-expressing pigs enable efficient in vivo genome editing. Genome Res. 27, 2061–2071 (2017).
Rieblinger, B. et al. Cas9-expressing chickens and pigs as resources for genome editing in livestock. Proc. Natl Acad. Sci. USA. 118, e2022562118 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Saur, D., Schnieke, A. Porcine cancer models for clinical translation. Nat Rev Cancer 22, 375–376 (2022). https://doi.org/10.1038/s41568-022-00467-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-022-00467-0
- Springer Nature Limited
This article is cited by
-
Is There a Mitochondrial Protection via Remote Ischemic Conditioning in Settings of Anticancer Therapy Cardiotoxicity?
Current Heart Failure Reports (2024)
-
Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein
Cancer Cell International (2023)